Aim: In this study, we aimed to investigate whether there was a significant prognostic difference between single and multiple cervical dilations when inducing second-trimester abortion. Methods: We conducted a retrospective review of 238 pregnant women who underwent termination of pregnancy at 12-21 weeks of gestation at Osaka University Hospital in Osaka, Japan, between January 2010 and May 2018. Termination of pregnancy was performed by vaginal administration of 1 mg gemeprost every 3 h for up to five doses per day after uterine cervical dilation using lamicel. Results: The women were categorized into two groups: 191 women had a delivery time of <24 h, whereas 47 had delivery times >24 h. Contrasting the groups, there were significant differences with regard to numbers of primiparas (88 [46.1%] and 32 [68.1%], respectively) and lamicel exchanges AE SD (1.9 AE 0.67 for <24 h and 2.4 AE 0.87 for >24 h, respectively). Additionally, we compared the prognosis of primiparas that received just a single lamicel with that of primiparas that had ≥2 exchanged, but no significant differences were noted in the number of patients with a delivery time of >24 h and the number of used gemeprost. Conclusion: Primipara is a risk factor for delayed delivery time of induced abortion. However, increasing the number of exchanged lamicel did not significantly reduce the delivery time; therefore, it should be performed as minimally as possible.
Introduction
There are two main methods of inducing abortion during the second trimester: medical and surgical (dilation and evacuation). In Japan, induced abortion is mainly performed by medical abortion, for which only gemeprost (16, 16 -dimethyl-trans delta-2-prostaglandin E1; Preglandin) is approved. Cervical dilation by osmotic dilator followed by administration of gemeprost is usually performed. Because the mental/emotional burden on patients is very high during second-trimester abortions, short hospital stays and high safety levels, with minimal risk are required.
Maturing and dilating the cervical canal before induction of labor increase the success rate of delivery, particularly in the case of primiparas. 1 Cervix softening using an osmotic dilator is the product of an inflammatory response to the physical force applied to open the cervix. 2 When performing cervical dilation using an osmotic dilator is relatively easy and does not require the physician to perform a high-level technique. Sufficient cervical dilation can reduce the risk of complications during induced abortion. 3 Conversely, insertion of an osmotic dilator can cause infection, cervical injury and allergic reactions [4] [5] [6] along with physical pain as well as non-negligible mental/emotional hardship. Gemeprost has several side effects including diarrhea, fever, and vomiting, and dosing is limited to five tablets per day, with 3 h between each administration. If the dose needs to be exceeded, hospitalization can be extended to accommodate additional administrations. Therefore, the minimum cervical dilatation method necessary to minimize physical as well as psychological burden is preferable.
Although less frequently observed during secondtrimester-induced labor, there is a risk of massive bleeding, uterine rupture and infection, particularly in patients with histories of previous cesarean sections or pregnancy complications, for which vaginal delivery is commonly performed. 7, 8 Although it is preferable to complete the induced abortion as safely and quickly as possible, it is still uncertain in which cases the delivery time is prolonged. It is controversial that delivery time is shortened by the combined use of osmotic dilation during second-trimester-induced abortions. [9] [10] [11] [12] [13] [14] [15] In addition, there has been a recent increase in use of synthetic osmotic dilators. The mean induction-abortion interval using lamicel was significantly shorter than that associated with using laminaria 16 ; however, there is no information on how delivery time can be shortened by increasing the number of osmotic dilators or by increasing the number of exchanges.
We investigated the risk factors associated with induced labor in the second trimester for cases requiring >24 h. This was a retrospective study of a single facility. In addition, we examined whether the delivery time could be shortened and whether the use of gemeprost could be decreased by increasing the number of synthetic osmotic dilators or by increasing the number of exchanges.
Methods
After obtaining institutional review board approval, we retrospectively reviewed the medical records of pregnant women undergoing induced abortion between 12 and 21 weeks of gestation, confirmed by ultrasound examination, at Osaka University Hospital (Osaka, Japan) from January 2010 to May 2018. The study was conducted in accordance with the ethical principles stated in the Declaration of Helsinki, and written informed consent for treatment was obtained from all of the patients. We evaluated whether induced abortions were completed in 24 h from administration of first gemeprost in cases of using synthetic osmotic dilator; lamicel. Exclusion criteria included women with spontaneous abortion, rupture of the membrane prior to cervical dilatation, prolapsed membrane, use of other osmotic dilators and lack of information (missing data).
The following data were collected retrospectively through chart review. Baseline maternal characteristics included age, nulliparity rate, maternal complications, the number of lamicel used until the first administration of gemeprost (each sizes S or L), and the number of gemeprost used. We evaluated the relationship between the number of lamicel used and the number of tablets of gemeprost used. This represents delivery time since gemeprost is administered every 3 h. The area of lamicel before expansion was calculated by following formula (S: 1.5 × 1.5 × 3.14 = 7.065 mm 2 , L: 2.5 × 2.5 × 3.14 = 19.625 mm 2 ). In general, the osmotic dilator expands four times the original size 17 thereby, S: area × 4 = 28.26, L: area × 4 = 78.5.
The area of the lamicel calculated above was defined as the cervical dilatation area. On the day before induced labor, cervical dilation was performed using lamicel. There was no protocol with regard to the number of osmotic dilators exchanged prior to the procedures. Lamicel exchange was performed based on the physician's preference at an interval of more than 3-4 h. Before inserting the lamicel, the position of the placenta was always checked with ultrasound to see whether it covered the internal ostium of the uterus. For patients with placenta previa, lamicel was carefully inserted so as to not go beyond the internal ostium. Women were taken to the delivery room the next morning and a physician removed all lamicel. Thereafter, a physician placed the gemeprost in the posterior fornix of the patient's vagina every 3 h, up to five tablets a day, until delivery was completed. If delivery was not completed on the first day, the gemeprost was placed in the vagina the next day and the same process was repeated until delivery was completed. The amount of blood loss was calculated at 2 and 5 h after delivery by weighing the blood absorbed by a paper sheet spread under the woman. The healthcare providers performing the examination were resident physicians or attending physicians.
Variables measured in interval scales are presented as means AE standard deviations, and statistical comparisons between groups were performed using the Wilcoxon/Kruskal-Wallis with JMP14 (SAS Institute, Inc.). Significant differences were defined as P-values <0.05.
Results
During the study period, 4691 women gave birth at Osaka University Hospital and 345 women underwent induced abortions. Of these, 107 were excluded from the study because of various reasons: 25 had spontaneous abortions, 13 had ruptured membranes prior to cervical dilatation, 3 had fetal membrane prolapse, 62 used other osmotic dilators that were not part of the study, 3 were missing data, and one used no lamicel prior to gemeprost. Consequently, we were able to examine 238 of the 345 women, 191 of whom experienced a time to delivery of less than 24 h. The remaining 47 delivered >24 h later.
The maternal characteristics are shown in Table 1 . The mean maternal age was 33.6 AE 5.6 years (within 24 h) and 31.8 AE 5.8 (>24 h). There were no significant differences in pre-pregnancy body mass index, gestational age at delivery, use of assisted reproductive technology, smokers, previous cesarean sections, placenta previa, analgesia, abortion, nor intrauterine fetal death (IUFD) between the two groups. However, there were significant differences in the numbers of primipara (88 [46.1%] and 32 [68.1%], respectively); and the numbers of lamicel exchange AE SD (1.9 AE 0.67 for within 24 h and 2.4 AE 0.87 for >24 h). The mean initial extended area AE SD for each group were 101.5 AE 51.4 (within 24 h) and 90.2 AE 41.2 (>24 h), and final extended area AE SD were 185.7 AE 88.0 (within 24 h) and 185.9 AE 95.8 (>24 h), thus showing no significant differences. Since significant differences in primipara were observed, as shown in Table 1 , the comparison of prognosis of the number of exchanged lamicel in primipara were also examined. Table 2 shows data of primiparas and Table 3 shows that of multiparas. The data were then split into two groups based on the number of times the lamicel was replaced: single or multiple. In primiparas, no significant differences were noted between the single group and multiple group in terms of: number of patients with a delivery time of >24 h (4 patients [26.7%] and 28 patients [26.7%], respectively); the number of used gemeprost AE SD (4.7 AE 2.2 and 4.4 AE 2.9, respectively). Interval from the initial osmotic dilator insertion to gemeprost was significantly longer in the multiple group than in that in the single group. Initial extended area was smaller and final extended area was larger in multiple group than those in the single group. Multiparas also showed similar result. The bleeding volume was significantly higher in the single group than that in the multiple group, except for multiparas; however, there were no transfusions or hysterectomies, and the length of hospital stay did not become increase in the single group. 
Discussion
In our study, when contrasting the duration of labor induction within 24 h against labor at >24 h for second-trimester abortion, there was a significant correlation with percent of primiparas according to group as well as the number of lamicel exchanges involved. However, when we examined just the primiparas for the effect of using just a single versus multiple exchanges, no significant difference was found in the incidence of delivery time being longer than 24 h or the number of gemeprost used.
A retrospective analysis of 932 pregnancies that were terminated using the gemeprost regimen, as described by Cameron et al., revealed that 20% and 15% of the women had not aborted by 24 and 48 h, respectively. 18 Our study showed a similar result: 19.7% (47/238) of women took >24 h from induction to delivery. The results of this study showed that delivery time was significantly longer for primiparas than for multiparas. A recent retrospective cohort study of induction of labor at term showed that multiparas and patients with a favorable cervix (>2 cm) were more likely to have a successful vaginal delivery and have a shorter length of induction. 19 The same conclusion was made by Laughon et al. 20 These studies suggest that the delivery time of primiparas tended to be longer than multiparas. Therefore, it is important to consider the risk of prolonged duration of labor induction in primiparas, and generate solutions as to how to shorten it. In other reports about second-trimester abortion, higher parity, the presence of IUFD, lower gestational age, and the presence of premature preterm rupture of membranes were significant factors associated with shorter induction-todelivery time. [21] [22] [23] In our study, IUFD and gestational age were not factors that influenced time to delivery of >24 h. This difference is likely due to study design. We excluded the cases with premature preterm rupture of membranes.
There are few reports about the relationship between osmotic dilators and delivery time in patients who undergo second-trimester abortion. There have been conflicting reports whether the use of osmotic dilators before labor induction, for termination of pregnancy during the second trimester, shortens the 10 Conversely, the placement of an osmotic dilator before induced abortion can significantly shorten induction-to-delivery time. 9, 14, 15 A recent retrospective cohort study reported that cervical ripening with laminaria (mean AE SD, 7.5 AE 6.2 h) significantly shortened the induction-to-delivery time compared to mifepristone and misoprostol only (12.7 AE 13.3 h).
14 The inductionto-delivery time was significantly longer in the PGE2-only group (689 min) compared with that of those who received PGE2 plus laminaria (487 min). 9 Although there have been reports of the use of gemeprost or misoprostol with or without laminaria for termination of pregnancy during the second trimester, our study seems to be the first, to our knowledge, to have examined prognosis according to the number of osmotic dilator exchanges in the second trimester. Our study could not determine that the delivery time was influenced by lamicel, however, our study indicated a correlation between the number of lamicel exchanges and elongated labor time of >24 h in second-trimester abortion. Furthermore, although the difference was not significant, the initial extension tended to be smaller in the >24-h group. When examining only the primiparas, there was no significant difference in delayed delivery and the number of used gemeprost by the number of lamicel exchanged, for single versus multiple. A prospective randomized study reported that, in primiparas at term, the time from Foley catheter insertion to delivery did not differ significantly between the single balloon (60 mL of normal saline) and double balloon catheter (80 mL of normal saline for each balloons). 24 Another study reported that double balloon had similar efficacy to single balloon catheter for induction at term. 25 These studies both suggest that the use of double balloon catheter could not shorten the delivery time when contrasted against the use of the single balloon catheter. Our study also showed that a larger final extended area did not shorten the delivery time. These results collectively indicate that having a larger dilated area does not necessarily shorten the delivery time. Our results indicate that the group with a delivery time of >24 h had a higher number of lamicel exchanges. This can be explained by the fact that they also had a smaller initial extended area, which triggered the physicians to exchange lamicel more than once. Although the increased number of exchanges did not shorten the duration of delivery and did not decrease the dose of gemeprost, further prospective study in a large sample size is warranted to prove this. Based on the above results, although being a primipara could be a factor in prolonging the delivery time, the number of lamicel exchanged was not a factor, as it was the result of having a smaller initial extended area. On the other hand, our study showed a small reduction in the bleeding volume in the multiple dilations group. There are some reports that adequate cervical dilation can decrease the risk of cervical laceration 3 and thus, we cannot consider these replacements as being entirely inappropriate.
In terms of study limitations, there were several. Because our study was a retrospective one, there was no protocol with regards to the number of osmotic dilators exchanged prior to the procedures. Although our study indicated that multiple dilations did not necessarily shorten the duration of delivery, in cases where the initial extended area was small, there was a tendency to insert the lamicel more than once, and a tendency to replace it more than twice. Moreover, in cases where the cervix was initially narrow, it remains unclear the specific minimum extended area (and thus the number of lamicel) that is ultimately required for successful termination. This will require further examination.
In conclusion, primipara is a risk factor for delayed delivery time in induced second-trimester abortions. However, increasing the number of lamicel exchanged did not result in significant shortening of delivery time. Although the appropriate number of lamicel to be exchanged for primiparas is still unclear, single lamicel insertion may have the same dilative effect as multiple exchange in multiparous women (or women with larger initial extended area). As even a single insertion of an osmotic dilator can place a heavy psycological and physical burden on the patient, we should, therefore, perform it as few times as possible.
and Technology of Japan and from the Japan Society for the Promotion of Science. The authors would like to thank Enago (www.enago.jp) for the English language review.
